These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [A case of retroperitoneal Castleman's disease with paraneoplastic pemphigus]. Zhang Z; Zhou M; Guo J; Feng T; Li X; Chen H; Li J Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 May; 41(5):548-52. PubMed ID: 27269932 [TBL] [Abstract][Full Text] [Related]
8. Successful immunomodulatory therapy in castleman disease with paraneoplastic pemphigus vulgaris. Miltenyi Z; Toth J; Gonda A; Tar I; Remenyik E; Illes A Pathol Oncol Res; 2009 Sep; 15(3):375-81. PubMed ID: 19067241 [TBL] [Abstract][Full Text] [Related]
9. Clinical and pathological features of bronchiolitis obliterans requiring lung transplantation in paraneoplastic pemphigus associated with Castleman disease. Chen W; Zhao L; Guo L; Zhao L; Niu H; Lian H; Dai H; Chen J; Wang C Clin Respir J; 2022 Mar; 16(3):173-181. PubMed ID: 35060328 [TBL] [Abstract][Full Text] [Related]
10. Clinical Analysis of Unicentric Castleman's Disease with Paraneoplastic Pemphigus and Bronchiolitis Obliterans. Zhen JF; Zhang L; Cao XX; Feng J; Zhou DB; Lin SB; Li J Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):492-498. PubMed ID: 28877826 [TBL] [Abstract][Full Text] [Related]
11. Paraneoplastic pemphigus and fatal bronchiolitis obliterans associated with Castleman disease: Report of an autopsy case. Sano Y; Kikuchi Y; Morita S; Oka T; Saito K; Takeda N; Terashima K; Toyota H; Uchida H; Watabe S; Numakura S; Miyoshi S; Nagase H; Kamata M; Tada Y; Uozaki H Pathol Int; 2021 Feb; 71(2):170-172. PubMed ID: 33382501 [No Abstract] [Full Text] [Related]
13. [Factors associated with long-term survival in critically ill patients following surgery for solid tumors complicated with paraneoplastic pemphigus]. Pan JX; Zhu SN; Li SL; Wang DX Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):981-990. PubMed ID: 36241242 [TBL] [Abstract][Full Text] [Related]
14. Castleman disease: CT and MR imaging features of a retroperitoneal location in association with paraneoplastic pemphigus. Irsutti M; Paul JL; Selves J; Railhac JJ Eur Radiol; 1999; 9(6):1219-21. PubMed ID: 10415265 [TBL] [Abstract][Full Text] [Related]
15. Tocilizumab Cannot Prevent the Development of Bronchiolitis Obliterans in Patients With Castleman Disease-Associated Paraneoplastic Pemphigus. Gu L; Ye S J Clin Rheumatol; 2019 Aug; 25(5):e77-e78. PubMed ID: 29389687 [No Abstract] [Full Text] [Related]
16. Paraneoplastic pemphigus presenting as a prodrome to aggressive T cell lymphoma. Bansari A; Wallace JA; Yang L; Kapoor A BMJ Case Rep; 2024 Jun; 17(6):. PubMed ID: 38839409 [TBL] [Abstract][Full Text] [Related]
18. Paraneoplastic pemphigus with fatal pulmonary involvement in a woman with a mesenteric Castleman tumour. Wolff H; Kunte C; Messer G; Rappersberger K; Held E; Löhrs U; Plewig G; Meurer M Br J Dermatol; 1999 Feb; 140(2):313-6. PubMed ID: 10233229 [TBL] [Abstract][Full Text] [Related]
19. [Bronchiolitis obliterans associated with paraneoplastic pemphigus: a paraneoplastic autoimmune multiorgan syndrome]. Iranzo P; Xaubet A; Carrera C; Mascaró JM; Campo E; Herrero C Arch Bronconeumol; 2004 May; 40(5):240-3. PubMed ID: 15117625 [TBL] [Abstract][Full Text] [Related]
20. Castleman disease and paraneoplastic pemphigus in a pregnant woman: A case report. Cui B; Lin H Medicine (Baltimore); 2021 Apr; 100(13):e24990. PubMed ID: 33787583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]